Monomethyl Fumarate
Thalassemia Major
M.D. Anderson Cancer CenterSmall moleculePhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 60/ 100
- Competitive Position
- 89/ 100
Competitive context
10 Active assets in the Thalassemia Major cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Deferiprone Pakistan Blood and Marrow Transplant (PBMT) Group | Phase 4 | BBB |
DESFERRIOXAMINE B Pakistan Blood and Marrow Transplant (PBMT) Group | Phase 4 | BBB |
TACROLIMUS M.D. Anderson Cancer Center | Phase 4 | BBB |
Fludarabine M.D. Anderson Cancer Center | Phase 4 | BBB |
Busulphan M.D. Anderson Cancer Center | Phase 4 | BBB |
View all 24 →
Same molecule, other indications
Monomethyl Fumarate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →